Cafepharma Today

September 26 2024 - AbbVie's Parkinson's disease drug meets main goal in late-stage trial
AbbVie's Parkinson's disease drug meets main goal in late-stage trial
Arch raises another $3B biotech fund in pursuit of ‘coolest’ new science
Biogen cuts ties with Sage on failed tremor drug
AZ gets sought-after lung cancer approval for Tagrisso
*please scroll down for all the latest news*

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

*please scroll down for all the latest news*

Current News

submit a press release

Will FDA label regs shield pharma?
Fierce Pharma
Monday, August 25, 2008 - 11:39am
tags:
Genzyme to help pursue malaria research
Bizjournals.com
Monday, August 25, 2008 - 11:12am
tags:
Early Glance: Biotechnology companies
Yahoo/AP
Monday, August 25, 2008 - 10:56am
tags:
Amgen is poised for higher opening following approval of rare blood-clotting disorder drug
Yahoo/AP
Monday, August 25, 2008 - 9:16am
tags:
Patients Taking Cymbalta(R) Experienced Reduced Chronic Low Back Pain in New Study
Yahoo
Monday, August 25, 2008 - 7:48am
tags:
Glaxo's HIV-Drug Ads Draw Critics
WSJ Online
Monday, August 25, 2008 - 6:06am
tags:
Ranbaxy Falls After Dow Says India to Review Purchase
Bloomberg
Monday, August 25, 2008 - 5:56am
tags:
Nicox says Pfizer drops glaucoma drug study in Asia
Yahoo/Reuters
Monday, August 25, 2008 - 5:55am
tags:
Eisai Wins U.S. Approval to Sell Nausea Drug Aloxi in Capsules
Bloomberg
Sunday, August 24, 2008 - 10:16pm
tags:
The Long Case for Pfizer
Seeking Alpha
Sunday, August 24, 2008 - 4:00pm
tags:
Dr Reddy's plans to brand US speciality drugs
Business Standard, India
Sunday, August 24, 2008 - 10:32am
tags:
Antibody Engineering Cuts the Collateral Damage of Cancer Drugs
Wired News
Sunday, August 24, 2008 - 10:30am
tags:
New FDA labels may protect drug makers
The News Journal, DE
Sunday, August 24, 2008 - 10:23am
tags:
FDA Approves ALOXI(R) (Palonosetron HCl) Capsules For Prevention Of Acute Chemotherapy Induced Nausea And Vomiting
Medical News Today
Sunday, August 24, 2008 - 10:22am
tags:
Long Uphill Climb Continues For Genetics Firms
Yahoo/Investors Business Daily
Saturday, August 23, 2008 - 2:07pm
tags:
Don't Worry About Vytorin's Cancer Risk
Motley Fool
Saturday, August 23, 2008 - 10:47am
tags:
Salix Pharmaceuticals Sells $60 Million Of Convertible Notes
Trading Markets
Saturday, August 23, 2008 - 10:43am
tags:
GSK to provide public with more information
San Antonio Business Journal, TX
Saturday, August 23, 2008 - 10:42am
tags:
PharmaGap Closes $1.1 million Public Portion of Anticipated $2.6 million Equity Financing; Announces Full Clinical Development Group to Take Lead Cancer Drug into Human Clinical Trials
CNW Telbec
Saturday, August 23, 2008 - 10:41am
tags:
Angiotech Announces Extension of the Expiration Date of its Tender Offer for Senior Floating Rate Notes Due 2013 and 7.75% Senior Subordinated Notes Due 2014
CNW Telbec, Canada
Saturday, August 23, 2008 - 10:39am
tags:

Pages

Latest CP Wire Articles

PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies
Sapio Sciences launches new drug discovery platform
Bristol Myers Squibb Strengthens and Diversifies Oncology Portfolio With Acquisition of Mirati Therapeutics
Why Medical and Pharma Sales Reps Should Start Their Own Senior Care Business
Bend Bioscience Adds Capacity and Technology Offerings with the Addition of New Process and Manufacturing Science Facility
Eastman introduces new excipient to formulate poorly soluble API

Latest Pharmagather Articles

Max Colao Shares How OncoVerity is Pioneering Oncology Solutions
pharmexec
Drug Channels News Roundup, September 2024: Inside JNJ’s Gross-to-Net Bubble, Optum Rx’s Private Label Biosimilars, Where Biosimilars Boom, Accumulators vs. Patients, and Steve Collis Retires
Drug Channels
Pharma Pulse 9/24/24: The Financial Benefits of Technology, Empathy Left Outside the Exam Room Door & more
pharmexec
The Impact of FDA’s Guidance on Mammography Quality Standards Act: Q&A with Steven C. Quay
pharmexec
What is a Mega Campus?
pharmexec
FDA Approves Sarclisa for Certain Patients with Multiple Myeloma
pharmexec
FDA Approves Bimzelx for Psoriatic Arthritis, Non-Radiographic Axial Spondyloarthritis, and Ankylosing Spondylitis
pharmexec
Stealing Protein Degrader Secrets?
In the Pipeline
Informa Connnect's Pharma/Biotech GTN Summit
Drug Channels

Latest Jobs

Pharmaceutical Sales Customer Engagement, CNS - Los Angeles East, CA
Los Angeles, California,
Otsuka
Pharmaceutical Sales Customer Engagement- Gainesville, FL
Gainesville, Florida,
Otsuka
Psychiatry Account Manager - Boise, ID
Boise, Idaho, US
Lundbeck
Pharmaceutical Sales Customer Engagement, CNS - Allentown, PA
Allentown, Pennsylvania,
Otsuka
Pharmaceutical Sales Customer Engagement, CNS - Morgantown, WV
Morgantown, West Virginia,
Otsuka
Pharmaceutical Sales Customer Engagement, CNS - Portland N, OR
Portland, Oregon,
Otsuka
Pharmaceutical Sales Customer Engagement - Zanesville-Portsmouth
Ohio, Ohio,
Otsuka
Pharmaceutical Sales Customer Engagement - Bangor, ME
Bangor, Maine,
Otsuka
Pharmaceutical Sales Customer Engagement - Danville-Reading
Reading, Pennsylvania,
Otsuka
Pharmaceutical Sales Customer Engagement - Springfield E, MO
Springfield, Missouri,
Otsuka
more jobs

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.

Do Not Allow Advertisers to Use My Personal information